Record Information |
---|
Version | 1.0 |
---|
Created at | 2022-09-04 06:04:38 UTC |
---|
Updated at | 2022-09-04 06:04:38 UTC |
---|
NP-MRD ID | NP0189575 |
---|
Secondary Accession Numbers | None |
---|
Natural Product Identification |
---|
Common Name | (12z,14e)-16-ethyl-3,6,8,9-tetrahydroxy-12-(methoxymethyl)-25,27-dimethyl-2-propyl-1-oxa-4-azacyclooctacosa-3,12,14-triene-20,28-dione |
---|
Description | Antibiotic TA, also known as myxovirescin, belongs to the class of organic compounds known as macrolide lactams. These are cyclic polyketides containing both a cyclic amide and a cyclic ester group. (12z,14e)-16-ethyl-3,6,8,9-tetrahydroxy-12-(methoxymethyl)-25,27-dimethyl-2-propyl-1-oxa-4-azacyclooctacosa-3,12,14-triene-20,28-dione is found in Myxococcus xanthus. It was first documented in 2006 (PMID: 16835859). Based on a literature review a significant number of articles have been published on Antibiotic TA (PMID: 31417013) (PMID: 30597714) (PMID: 27116009) (PMID: 26264037) (PMID: 26239730) (PMID: 24391051). |
---|
Structure | CCCC1OC(=O)C(C)CC(C)CCCCC(=O)CCCC(CC)\C=C\C=C(COC)\CCC(O)C(O)CC(O)CN=C1O InChI=1S/C35H61NO8/c1-6-12-33-34(41)36-23-30(38)22-32(40)31(39)20-19-28(24-43-5)16-10-14-27(7-2)15-11-18-29(37)17-9-8-13-25(3)21-26(4)35(42)44-33/h10,14,16,25-27,30-33,38-40H,6-9,11-13,15,17-24H2,1-5H3,(H,36,41)/b14-10+,28-16- |
---|
Synonyms | Value | Source |
---|
Myxococcus xanthus antibiotic ta | MeSH | Myxovirescin | MeSH |
|
---|
Chemical Formula | C35H61NO8 |
---|
Average Mass | 623.8720 Da |
---|
Monoisotopic Mass | 623.43972 Da |
---|
IUPAC Name | (12Z,14E)-16-ethyl-3,6,8,9-tetrahydroxy-12-(methoxymethyl)-25,27-dimethyl-2-propyl-1-oxa-4-azacyclooctacosa-3,12,14-triene-20,28-dione |
---|
Traditional Name | antibiotic TA |
---|
CAS Registry Number | Not Available |
---|
SMILES | CCCC1OC(=O)C(C)CC(C)CCCCC(=O)CCCC(CC)\C=C\C=C(COC)\CCC(O)C(O)CC(O)CN=C1O |
---|
InChI Identifier | InChI=1S/C35H61NO8/c1-6-12-33-34(41)36-23-30(38)22-32(40)31(39)20-19-28(24-43-5)16-10-14-27(7-2)15-11-18-29(37)17-9-8-13-25(3)21-26(4)35(42)44-33/h10,14,16,25-27,30-33,38-40H,6-9,11-13,15,17-24H2,1-5H3,(H,36,41)/b14-10+,28-16- |
---|
InChI Key | VQWNGCSUNKJFLW-ACPVBGRSSA-N |
---|
Experimental Spectra |
---|
|
| Not Available | Predicted Spectra |
---|
|
| Spectrum Type | Description | Depositor ID | Depositor Organization | Depositor | Deposition Date | View |
---|
1D NMR | 13C NMR Spectrum (1D, 25 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 100 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 252 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 1000 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 50 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 200 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 75 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 300 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 101 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 400 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 126 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 500 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 151 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 600 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 176 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 700 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 201 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 800 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 226 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 900 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum |
| Chemical Shift Submissions |
---|
|
| Not Available | Species |
---|
Species of Origin | |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as macrolide lactams. These are cyclic polyketides containing both a cyclic amide and a cyclic ester group. |
---|
Kingdom | Organic compounds |
---|
Super Class | Phenylpropanoids and polyketides |
---|
Class | Macrolide lactams |
---|
Sub Class | Not Available |
---|
Direct Parent | Macrolide lactams |
---|
Alternative Parents | |
---|
Substituents | - Macrolide lactam
- Macrolactam
- Macrolide
- Carboxamide group
- Carboxylic acid ester
- Ketone
- Lactam
- Lactone
- Cyclic ketone
- Secondary carboxylic acid amide
- Secondary alcohol
- Carboxylic acid derivative
- Dialkyl ether
- Ether
- Oxacycle
- Azacycle
- Organoheterocyclic compound
- Monocarboxylic acid or derivatives
- Polyol
- Organic oxide
- Organopnictogen compound
- Hydrocarbon derivative
- Organic nitrogen compound
- Alcohol
- Organic oxygen compound
- Organonitrogen compound
- Organooxygen compound
- Carbonyl group
- Aliphatic heteromonocyclic compound
|
---|
Molecular Framework | Aliphatic heteromonocyclic compounds |
---|
External Descriptors | |
---|
Physical Properties |
---|
State | Not Available |
---|
Experimental Properties | Property | Value | Reference |
---|
Melting Point | Not Available | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | Not Available | Not Available | LogP | Not Available | Not Available |
|
---|
Predicted Properties | |
---|
General References | - Simunovic V, Zapp J, Rachid S, Krug D, Meiser P, Muller R: Myxovirescin A biosynthesis is directed by hybrid polyketide synthases/nonribosomal peptide synthetase, 3-hydroxy-3-methylglutaryl-CoA synthases, and trans-acting acyltransferases. Chembiochem. 2006 Aug;7(8):1206-20. doi: 10.1002/cbic.200600075. [PubMed:16835859 ]
- Doherty AF, Ikuerowo SO, Jeje EA, Ibrahim NA, Ojongbede OL, Mutiu WB, Omisanjo OA, Abolarinwa AA: A prospective randomized comparative study of targeted versus empirical prophylactic antibiotics in the prevention of infective complications following transrectal ultrasound-guided prostate biopsy. Ann Afr Med. 2019 Jul-Sep;18(3):132-137. doi: 10.4103/aam.aam_48_18. [PubMed:31417013 ]
- Zancan RF, Calefi PHS, Borges MMB, Lopes MRM, de Andrade FB, Vivan RR, Duarte MAH: Antimicrobial activity of intracanal medications against both Enterococcus faecalis and Candida albicans biofilm. Microsc Res Tech. 2019 May;82(5):494-500. doi: 10.1002/jemt.23192. Epub 2018 Dec 29. [PubMed:30597714 ]
- Hurley JC: Impact of selective digestive decontamination on respiratory tract Candida among patients with suspected ventilator-associated pneumonia. A meta-analysis. Eur J Clin Microbiol Infect Dis. 2016 Jul;35(7):1121-35. doi: 10.1007/s10096-016-2643-7. Epub 2016 Apr 26. [PubMed:27116009 ]
- Santos AF, Matos M, Sousa A, Costa C, Nogueira R, Teixeira JA, Paiva PM, Parpot P, Coelho LC, Brito AG: Removal of tetracycline from contaminated water by Moringa oleifera seed preparations. Environ Technol. 2016;37(6):744-51. doi: 10.1080/09593330.2015.1080309. Epub 2015 Sep 15. [PubMed:26264037 ]
- Hurley JC: ICU-acquired candidemia within selective digestive decontamination studies: a meta-analysis. Intensive Care Med. 2015 Nov;41(11):1877-85. doi: 10.1007/s00134-015-4004-x. Epub 2015 Aug 4. [PubMed:26239730 ]
- Xiao Y, Wall D: Genetic redundancy, proximity, and functionality of lspA, the target of antibiotic TA, in the Myxococcus xanthus producer strain. J Bacteriol. 2014 Mar;196(6):1174-83. doi: 10.1128/JB.01361-13. Epub 2014 Jan 3. [PubMed:24391051 ]
- Xiao Y, Gerth K, Muller R, Wall D: Myxobacterium-produced antibiotic TA (myxovirescin) inhibits type II signal peptidase. Antimicrob Agents Chemother. 2012 Apr;56(4):2014-21. doi: 10.1128/AAC.06148-11. Epub 2012 Jan 9. [PubMed:22232277 ]
- Xiao Y, Wei X, Ebright R, Wall D: Antibiotic production by myxobacteria plays a role in predation. J Bacteriol. 2011 Sep;193(18):4626-33. doi: 10.1128/JB.05052-11. Epub 2011 Jul 15. [PubMed:21764930 ]
- Kusachi S, Nagao J, Saida Y, Watanabe M, Okamoto Y, Asai K, Nakamura Y, Enomoto T, Arima Y, Kiribayashi T, Watanabe R, Saito T, Uramatsu M, Sato J: Antibiotic time-lag combination therapy with fosfomycin for postoperative intra-abdominal abscesses. J Infect Chemother. 2011 Feb;17(1):91-6. doi: 10.1007/s10156-010-0167-0. Epub 2010 Dec 3. [PubMed:21127935 ]
- LOTUS database [Link]
|
---|